NAVCO Pharmaceuticals Inc. (TSXV:NAV)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Sep 24, 2026, 1:45 PM EST
NAVCO Pharmaceuticals Statistics
Total Valuation
TSXV:NAV has a market cap or net worth of CAD 285,348. The enterprise value is 395,757.
| Market Cap | 285,348 |
| Enterprise Value | 395,757 |
Important Dates
The next estimated earnings date is Friday, January 29, 2027.
| Earnings Date | Jan 29, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:NAV has 57.07 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 57.07M |
| Shares Outstanding | 57.07M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.49% |
| Owned by Institutions (%) | n/a |
| Float | 51.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.19 |
| Interest Coverage | -3.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -741.21% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 4.28% |
| Weighted Average Cost of Capital (WACC) | 13.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.14 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 44.54 |
| Average Volume (20 Days) | 19,133 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -41,354 |
| Pretax Income | -68,839 |
| Net Income | -68,839 |
| EBITDA | n/a |
| EBIT | -41,354 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 290 in cash and 110,700 in debt, with a net cash position of -110,410 or -0.00 per share.
| Cash & Cash Equivalents | 290 |
| Total Debt | 110,700 |
| Net Cash | -110,410 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -965,378 |
| Book Value Per Share | -0.02 |
| Working Capital | -965,378 |
Cash Flow
| Operating Cash Flow | -26,393 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 20,000 |
| Free Cash Flow | -26,393 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:NAV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.02% |
| Earnings Yield | -24.12% |
| FCF Yield | -9.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |